Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,600
Closed -$63K 6178
2020
Q1
$63K Sell
3,600
-17,200
-83% -$530K ﹤0.01% 5089
2019
Q4
$815K Buy
20,800
+9,600
+86% +$353K ﹤0.01% 3858
2019
Q3
$401K Buy
11,200
+4,300
+62% +$154K ﹤0.01% 4418
2019
Q2
$242K Buy
6,900
+6,266
+988% +$218K ﹤0.01% 4942
2019
Q1
$22K Sell
634
-7,866
-93% -$289K ﹤0.01% 6325
2018
Q4
$272K Buy
8,500
+3,400
+67% +$128K ﹤0.01% 4357
2018
Q3
$234K Sell
5,100
-3,600
-41% -$181K ﹤0.01% 4878
2018
Q2
$460K Buy
8,700
+1,100
+14% +$58.5K ﹤0.01% 4028
2018
Q1
$380K Sell
7,600
-2,300
-23% -$116K ﹤0.01% 4233
2017
Q4
$475K Buy
9,900
+5,500
+125% +$261K ﹤0.01% 3887
2017
Q3
$203K Buy
4,400
+2,500
+132% +$108K ﹤0.01% 4413
2017
Q2
$84K Sell
1,900
-27,600
-94% -$1.16M ﹤0.01% 5042
2017
Q1
$1.21M Sell
29,500
-7,700
-21% -$321K ﹤0.01% 2564
2016
Q4
$1.53M Buy
37,200
+31,100
+510% +$1.14M ﹤0.01% 2358
2016
Q3
$198K Sell
6,100
-2,600
-30% -$81.6K ﹤0.01% 3978
2016
Q2
$252K Buy
8,700
+2,500
+40% +$75.9K ﹤0.01% 3755
2016
Q1
$174K Buy
6,200
+1,848
+42% +$53K ﹤0.01% 3939
2015
Q4
$139K Sell
4,352
-5,000
-53% -$159K ﹤0.01% 4184
2015
Q3
$271K Sell
9,352
-5,000
-35% -$153K ﹤0.01% 3899
2015
Q2
$431K Sell
14,352
-300
-2% -$8.68K ﹤0.01% 3587
2015
Q1
$410K Sell
14,652
-3,880
-21% -$105K ﹤0.01% 3781
2014
Q4
$500K Buy
18,532
+5,000
+37% +$126K ﹤0.01% 3865
2014
Q3
$311K Buy
13,532
+4,558
+51% +$109K ﹤0.01% 4371
2014
Q2
$215K Buy
8,974
+560
+7% +$13.1K ﹤0.01% 4749
2014
Q1
$177K Sell
8,414
-3,757
-31% -$91.4K ﹤0.01% 4896
2013
Q4
$256K Buy
12,171
+1,271
+12% +$30K ﹤0.01% 4771
2013
Q3
$229K Buy
10,900
+5,414
+99% +$123K ﹤0.01% 4910
2013
Q2
$112K Buy
+5,486
New +$104K ﹤0.01% 5701

Other funds holding SNV

Barclays's SNV Position: Q1 2026 in Review

Barclays sold out of Synovus (SNV) in Q1 2026, closing a stake of 214,046 shares — an estimated $10.7M sold.

Barclays first reported a position in SNV in Q2 2013 and held it in 51 quarters. The position peaked at $59.4M in Q3 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Barclays reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Barclays sold 214,046 Synovus shares in Q1 2026, an estimated $10.7M.
  • Barclays first reported a position in Synovus in Q2 2013 and held it in 51 quarters.
  • Barclays's Synovus position peaked at $59.4M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.